Jade Biosciences, Inc. (JBIO)
20.02
-1.38
(-6.45%)
USD |
NASDAQ |
Sep 03, 12:54
Jade Biosciences Price to Book Value : 2.892 for Sept. 3, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 02, 2026 | 3.092 |
| September 01, 2026 | 3.037 |
| August 31, 2026 | 3.086 |
| August 28, 2026 | 3.011 |
| August 27, 2026 | 3.076 |
| August 26, 2026 | 3.082 |
| August 25, 2026 | 3.155 |
| August 24, 2026 | 3.082 |
| August 21, 2026 | 3.083 |
| August 20, 2026 | 3.067 |
| August 19, 2026 | 3.258 |
| August 18, 2026 | 3.402 |
| August 17, 2026 | 3.388 |
| August 14, 2026 | 3.57 |
| August 13, 2026 | 3.440 |
| August 12, 2026 | 3.353 |
| August 11, 2026 | 3.229 |
| August 10, 2026 | 3.139 |
| August 07, 2026 | 3.173 |
| August 06, 2026 | 3.213 |
| August 05, 2026 | 3.135 |
| August 04, 2026 | 3.084 |
| August 03, 2026 | 2.767 |
| July 31, 2026 | 2.853 |
| July 30, 2026 | 2.890 |
| Date | Value |
|---|---|
| July 29, 2026 | 2.796 |
| July 28, 2026 | 2.846 |
| July 27, 2026 | 2.882 |
| July 24, 2026 | 2.901 |
| July 23, 2026 | 2.835 |
| July 22, 2026 | 2.868 |
| July 21, 2026 | 2.966 |
| July 20, 2026 | 2.842 |
| July 17, 2026 | 3.014 |
| July 16, 2026 | 2.959 |
| July 15, 2026 | 3.158 |
| July 14, 2026 | 3.083 |
| July 13, 2026 | 3.077 |
| July 10, 2026 | 3.027 |
| July 09, 2026 | 3.248 |
| July 08, 2026 | 3.255 |
| July 07, 2026 | 3.243 |
| July 06, 2026 | 3.077 |
| July 02, 2026 | 3.108 |
| July 01, 2026 | 3.151 |
| June 30, 2026 | 3.210 |
| June 29, 2026 | 3.680 |
| June 26, 2026 | 3.662 |
| June 25, 2026 | 3.630 |
| June 24, 2026 | 3.645 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Perspective Therapeutics, Inc. | 1.092 |
| Cue Biopharma, Inc. | 63.09 |
| Praxis Precision Medicines, Inc. | 7.385 |
| Opus Genetics, Inc. | -- |
| Faeth Therapeutics, Inc. | 5.886 |
Price to Book Value Related Metrics
| Price | 20.02 |
| Earnings Yield | -13.06% |
| Market Cap | 1.272B |